Opioid epidemic
Opioid Epidemic is a term that refers to the rapid increase in the use of prescription and non-prescription opioid drugs in the United States and Canada in the 2010s. The epidemic has resulted in significant increases in opioid addiction, overdoses, and deaths.
Overview[edit]
The opioid epidemic has been described as one of the deadliest drug crises in American history. Overdoses from opioids, including prescription opioids, heroin, and synthetic opioids such as fentanyl, have skyrocketed over the past decade. The crisis began in the late 1990s when pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers. As a result, healthcare providers began to prescribe them at greater rates, leading to widespread misuse.
Causes[edit]
The opioid epidemic has been driven by multiple factors. These include aggressive marketing by pharmaceutical companies, overprescription by doctors, and the proliferation of cheap, potent synthetic opioids like fentanyl. In addition, societal factors such as poverty, unemployment, and lack of access to mental health services have contributed to the crisis.
Impact[edit]
The opioid epidemic has had a devastating impact on individuals, families, and communities. It has resulted in a significant increase in opioid-related deaths, with over 400,000 people dying from overdoses involving prescription or illicit opioids in the United States between 1999 and 2017. The crisis has also strained healthcare and criminal justice systems, and has had significant economic costs.
Prevention and Treatment[edit]
Efforts to address the opioid epidemic include prevention strategies, such as improving prescribing practices and expanding access to naloxone, a medication that can reverse an opioid overdose. Treatment strategies include increasing access to medication-assisted treatment (MAT), which combines behavioral therapy and medications to treat substance use disorders.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
